News
We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education ...
Unlock the power of AI to transform pharma medical education, training, and critical insight gathering. Discover how next-gen ...
Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track ...
LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...
Johnson & Johnson (J&J) has announced that its CD38-directed antibody Darzalex (daratumumab) has been approved by the ...
Havas Lynx announces the appointment of Ayesha Walawalkar as Chief Strategy Officer, and Talin Apkarian as Havas Lynx Hudson Managing Director.
Abivax has shared positive top-line results from two late-stage studies of its investigational oral miR-124 enhancer in adults with moderately to severely active ulcerative colitis (UC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results